BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7756689)

  • 1. In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms.
    Koechli OR; Schaer GN; Sevin BU; Perras JP; Schenk V; Rodriguez M; Untch M; Steren A; Haller U
    Anticancer Drugs; 1995 Feb; 6(1):94-100. PubMed ID: 7756689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
    Wong LC; Choo YC; Ma HK
    Cancer; 1986 Jul; 58(1):14-7. PubMed ID: 3011237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational and nongestational trophoblastic neoplasia: a historic and pathobiologic survey.
    Dehner LP
    Am J Surg Pathol; 1980 Feb; 4(1):43-58. PubMed ID: 6244747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gestational trophoblastic disease.
    Seckl MJ; Newlands ES
    Gen Diagn Pathol; 1997 Nov; 143(2-3):159-71. PubMed ID: 9443572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 6. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP
    Cancer; 1995 Nov; 76(10 Suppl):2079-85. PubMed ID: 8635004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapy.
    Bolze PA; Lopez J; Allias F; Hajri T; Patrier S; Devouassoux-Shisheboran M; Massardier J; You B; Golfier F; Mallet F
    Gynecol Oncol; 2020 Sep; 158(3):785-793. PubMed ID: 32513563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and treatment of choriocarcinoma and related trophoblastic tumors in women].
    Hertz R
    Geburtshilfe Frauenheilkd; 1968 Sep; 28(9):809-23. PubMed ID: 4304185
    [No Abstract]   [Full Text] [Related]  

  • 10. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
    Lurain JR
    Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of gestational trophoblastic tumors.
    Hansen LA; Clayton BD
    Drug Intell Clin Pharm; 1984; 18(7-8):569-76. PubMed ID: 6086260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and prognosis of trophoblastic tumors].
    Holzmann K; Ninagawa T; Lohe K
    Geburtshilfe Frauenheilkd; 1970 Aug; 30(8):687-713. PubMed ID: 4329223
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
    Luschin-Ebengreuth G; Petru E; Pickel H
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():125-6. PubMed ID: 1337488
    [No Abstract]   [Full Text] [Related]  

  • 14. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors.
    Rustin GJ; Rustin F; Dent J; Booth M; Salt S; Bagshawe KD
    N Engl J Med; 1983 Mar; 308(9):473-6. PubMed ID: 6296679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of gestational trophoblastic disease.
    Redline RW; Abdul-Karim FW
    Semin Oncol; 1995 Apr; 22(2):96-108. PubMed ID: 7740321
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell lines.
    Nguyen HN; Sevin BU; Averette HE; Perras J; Donato D; Penalver M
    Gynecol Oncol; 1992 May; 45(2):185-91. PubMed ID: 1592285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Up-to-date diagnosis and therapy of trophoblastic diseases].
    Gáti I
    Orv Hetil; 1988 Sep; 129(38):2011-6. PubMed ID: 2845332
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor.
    Lage JM; Berkowitz RS; Rice LW; Goldstein DP; Bernstein MR; Weinberg DS
    Obstet Gynecol; 1991 Jan; 77(1):111-5. PubMed ID: 1845777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gestational trophoblastic tumors and recent clinical information].
    Shimizu T; Yaegashi N
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and radiological features of gestational trophoblastic tumors].
    Mamouni N; Boumhaoued S; Erraghay S; Boubou M; Bouchikhi C; Banani A
    Pan Afr Med J; 2017; 28():228. PubMed ID: 29629014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.